Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Infliximab

5

XII.d Myocarditis (can be fulminant)

1
Last update : 14/12/2019
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Biosimilars
1
Infliximab biosimilar
1
TNF-alpha antagonists / inhibitors
5

Publications

A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.
Cureus 2022 Jun;14;e26366 2022 Jun
[Childhood Interstitial Lung Disease in Infancy. Classification, diagnosis and management].
Archivos argentinos de pediatria 2019 Apr;117;S120-S134 2019 Apr
Hypersensitivity perimyocarditis after the first dose of infliximab.
Revista espanola de enfermedades digestivas 2015 Apr;107;249 2015 Apr
Myocarditis associated with infliximab: a case report and review of the literature.
Inflammatory bowel diseases 2011 Jul;17;1633-4 2011 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About